153 related articles for article (PubMed ID: 22171706)
1. Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings--what, why and how?
Yang XL; Ma RC; So WY; Kong AP; Xu G; Chan JC
Diabetes Obes Metab; 2012 Jul; 14(7):579-85. PubMed ID: 22171706
[TBL] [Abstract][Full Text] [Related]
2. Methodological challenges to control for immortal time bias in addressing drug effects in type 2 diabetes.
Yang XL; Huo XX; Chan JC
World J Methodol; 2015 Sep; 5(3):122-6. PubMed ID: 26413484
[TBL] [Abstract][Full Text] [Related]
3. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.
Simon D; Balkau B
Diabetes; 2010 Nov; 59(11):e25. PubMed ID: 20980467
[No Abstract] [Full Text] [Related]
4. Immortal time bias in pharmaco-epidemiology.
Suissa S
Am J Epidemiol; 2008 Feb; 167(4):492-9. PubMed ID: 18056625
[TBL] [Abstract][Full Text] [Related]
5. Diabetes and cancer: a consensus report.
Giovannucci E; Harlan DM; Archer MC; Bergenstal RM; Gapstur SM; Habel LA; Pollak M; Regensteiner JG; Yee D
CA Cancer J Clin; 2010; 60(4):207-21. PubMed ID: 20554718
[TBL] [Abstract][Full Text] [Related]
6. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).
Schiel R; Müller UA; Braun A; Stein G; Kath R
Eur J Med Res; 2005 Aug; 10(8):339-44. PubMed ID: 16131475
[TBL] [Abstract][Full Text] [Related]
7. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.
Vigneri R; Sava L; Squatrito S; Sciacca L
Diabetes; 2010 Nov; 59(11):e24. PubMed ID: 20980466
[No Abstract] [Full Text] [Related]
8. Beware of registries for their biases.
Yazici H
Bull NYU Hosp Jt Dis; 2012; 70(2):95-8. PubMed ID: 22891998
[TBL] [Abstract][Full Text] [Related]
9. Metformin and Reduced Risk of Cancer in the Hong Kong Diabetes Registry: Real Effect or Immortal Time Bias?
Zhang ZJ
J Gen Intern Med; 2019 Jul; 34(7):1154-1157. PubMed ID: 31025306
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
Rekers H; Norpoth T; Michaels MA
Eur J Contracept Reprod Health Care; 1996; 1(1):21-30. PubMed ID: 9678134
[TBL] [Abstract][Full Text] [Related]
11. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
[TBL] [Abstract][Full Text] [Related]
12. Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes.
Idris I; Warren G; Donnelly R
Arch Intern Med; 2012 Jul; 172(13):1005-11. PubMed ID: 22688528
[TBL] [Abstract][Full Text] [Related]
13. Parental history of diabetes in an insulin-treated diabetes registry.
Riley MD; Blizzard CL; McCarty DJ; Senator GB; Dwyer T; Zimmet P
Diabet Med; 1997 Jan; 14(1):35-41. PubMed ID: 9017351
[TBL] [Abstract][Full Text] [Related]
14. Immortal time bias in observational studies of drug effects.
Suissa S
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):241-9. PubMed ID: 17252614
[TBL] [Abstract][Full Text] [Related]
15. Cancer risks in thiazolidinedione users compared to other anti-diabetic agents.
Koro C; Barrett S; Qizilbash N
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):485-92. PubMed ID: 17192841
[TBL] [Abstract][Full Text] [Related]
16. [Diabetes, insulin, insulin analogues, and cancer].
Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
[TBL] [Abstract][Full Text] [Related]
17. The impact of bias in MoM values on patient risk and screening performance for Down syndrome.
Nix B; Wright D; Baker A
Prenat Diagn; 2007 Sep; 27(9):840-5. PubMed ID: 17600858
[TBL] [Abstract][Full Text] [Related]
18. The addition of pioglitazone in type 2 diabetics poorly controlled on insulin therapy: a meta-analysis.
Tan A; Cao Y; Xia N; Mo Z; Gao F
Eur J Intern Med; 2010 Oct; 21(5):398-403. PubMed ID: 20816593
[TBL] [Abstract][Full Text] [Related]
19. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
Lawrence G; Wallis M; Allgood P; Nagtegaal ID; Warwick J; Cafferty FH; Houssami N; Kearins O; Tappenden N; O'Sullivan E; Duffy SW
Breast Cancer Res Treat; 2009 Jul; 116(1):179-85. PubMed ID: 18622697
[TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes in patients with insulin-dependent versus non-insulin dependent diabetes mellitus receiving drug-eluting stents (from the first phase of the prospective multicenter German DES.DE registry).
Akin I; Bufe A; Eckardt L; Reinecke H; Senges J; Richardt G; Kuck KH; Schneider S; Nienaber CA;
Am J Cardiol; 2010 Nov; 106(9):1201-7. PubMed ID: 21029813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
